Amgen (AMGN) Accumulated Expenses (2009 - 2026)
Amgen's quarterly Accumulated Expenses came in at $16.6 billion in Q1 2026, down 3.78% year-on-year from $17.2 billion in Q1 2025, and down 10.47% quarter-over-quarter from $18.5 billion in Q4 2025.
Amgen has reported Accumulated Expenses for 18 years, with the latest figure at $16.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 3.78% year-over-year to $16.6 billion; the trailing twelve-month figure through Mar 2026 stood at $16.6 billion (down 3.78% YoY), and the FY2025 full-year result was $18.5 billion, up 5.0% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $16.6 billion, down from $18.5 billion in the prior quarter.
- The five-year high for Accumulated Expenses was $18.5 billion in Q4 2025, with the low at $10.5 billion in Q2 2022.
- Average Accumulated Expenses over 5 years is $14.4 billion, with a median of $14.2 billion recorded in 2023.
- Year-over-year, Accumulated Expenses jumped 30.09% in 2023 and fell 3.78% in 2026.
- Tracing AMGN's Accumulated Expenses over 5 years: stood at $12.5 billion in 2022, then increased by 22.64% to $15.4 billion in 2023, then advanced by 14.86% to $17.6 billion in 2024, then advanced by 5.0% to $18.5 billion in 2025, then decreased by 10.47% to $16.6 billion in 2026.
- The last three Accumulated Expenses figures came in at $16.6 billion (Q1 2026), $18.5 billion (Q4 2025), and $16.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.58 Bn |
| Dec 31, 2025 | 18.52 Bn |
| Sep 30, 2025 | 16.80 Bn |
| Jun 30, 2025 | 15.02 Bn |
| Mar 31, 2025 | 17.23 Bn |
| Dec 31, 2024 | 17.64 Bn |
| Sep 30, 2024 | 14.62 Bn |
| Jun 30, 2024 | 13.72 Bn |
| Mar 31, 2024 | 14.13 Bn |
| Dec 31, 2023 | 15.36 Bn |
| Sep 30, 2023 | 14.17 Bn |
| Jun 30, 2023 | 13.72 Bn |
| Mar 31, 2023 | 12.06 Bn |
| Dec 31, 2022 | 12.52 Bn |
| Sep 30, 2022 | 11.58 Bn |
| Jun 30, 2022 | 10.55 Bn |
| Mar 31, 2022 | 10.64 Bn |
| Dec 31, 2021 | 10.73 Bn |
| Sep 30, 2021 | 9.38 Bn |
| Jun 30, 2021 | 8.98 Bn |
| Mar 31, 2021 | 9.92 Bn |
| Dec 31, 2020 | 10.14 Bn |
| Sep 30, 2020 | 8.70 Bn |
| Jun 30, 2020 | 9.28 Bn |
| Mar 31, 2020 | 8.65 Bn |
| Dec 31, 2019 | 8.51 Bn |
| Sep 30, 2019 | 7.68 Bn |
| Jun 30, 2019 | 6.81 Bn |
| Mar 31, 2019 | 7.91 Bn |
| Dec 31, 2018 | 7.86 Bn |
| Sep 30, 2018 | 6.31 Bn |
| Jun 30, 2018 | 5.89 Bn |
| Mar 31, 2018 | 7.21 Bn |
| Dec 31, 2017 | 6.52 Bn |
| Sep 30, 2017 | 5.32 Bn |
| Jun 30, 2017 | 5.47 Bn |
| Mar 31, 2017 | 5.82 Bn |
| Dec 31, 2016 | 5.88 Bn |
| Sep 30, 2016 | 4.92 Bn |
| Jun 30, 2016 | 4.67 Bn |
| Mar 31, 2016 | 5.46 Bn |
| Dec 31, 2015 | 5.45 Bn |
| Sep 30, 2015 | 4.85 Bn |
| Jun 30, 2015 | 4.71 Bn |
| Mar 31, 2015 | 4.95 Bn |
| Dec 31, 2014 | 5.51 Bn |
| Sep 30, 2014 | 5.10 Bn |
| Jun 30, 2014 | 4.38 Bn |
| Mar 31, 2014 | 4.75 Bn |
| Dec 31, 2013 | 4.66 Bn |
| Sep 30, 2013 | 3.94 Bn |
| Jun 30, 2013 | 3.77 Bn |
| Mar 31, 2013 | 4.20 Bn |
| Dec 31, 2012 | 4.79 Bn |
| Sep 30, 2012 | 5.03 Bn |
| Dec 31, 2011 | 5.03 Bn |
| Mar 31, 2010 | 3.30 Bn |
| Dec 31, 2009 | 3.30 Bn |
| Sep 30, 2009 | 3.29 Bn |
| Jun 30, 2009 | 2.91 Bn |